Skip to main content
ADAPY logo

ADAPY · Adaptimmune Therapeutics PLC

Track ADAPY — free
$0.03 +0.01 (+22.81%) At close · Aug 28
Market Cap
$44.53M
Shares
1.59B

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2025-09-02 Gavin Wood 16,000
2025-08-29 William Bertrand 34,500
2025-08-15 New Enterprise Associates, 16 LP 3,250,000
2025-08-15 New Enterprise Associates, 14 LP 13,829,778
2025-01-17 Norry Elliot 5,584
2025-01-17 Rawcliffe Adrian 30,601
2025-01-17 Lunger John 5,584
2025-01-17 Bertrand William C JR 5,584
2025-01-15 Piccina Cintia 12,991
2025-01-15 Lunger John 9,739
2025-01-15 Norry Elliot 12,392
2025-01-15 Rawcliffe Adrian 30,473
2025-01-15 Bertrand William C JR 9,739
Showing 1–13 of 13 filings
Key facts CIK 1621227 CUSIP 00653A107 Visit website Investor relations